Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Dongshan Bay

PROVIDER: PRJNA637472 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11929900_1.fastq.gz	Fastqsanger.gz
	SRR11929900_2.fastq.gz	Fastqsanger.gz
	SRR11929901_1.fastq.gz	Fastqsanger.gz
	SRR11929901_2.fastq.gz	Fastqsanger.gz
	SRR11929902_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 80

Similar Datasets

Seawater metagenome from Dongshan Bay

Project description:Seawater metagenome from Dongshan Bay

| PRJNA1532013 | ENA

Project description:Dongshan Bay (China) benthic microbial eukaryotes

| PRJNA645757 | ENA

Project description:Seawater metagenome from , Dongshan Bay, Fujian, China

| PRJNA1532396 | ENA

Project description:Vibrio distribution across coral reef habitatsin Dongshan Bay, China

| PRJNA1528837 | ENA

Project description:Total and active fungal communities and functions in Dongshan bay

| PRJNA721236 | ENA

Project description:Total and active Vibrio communities and abundance in Dongshan bay

| PRJNA723986 | ENA

sediment metagenome

Project description:Dongshan Genome sequencing

| PRJNA259273 | ENA

Project description:Study on Bacterial Diversity of Corals and Their Surrounding Environment in Dongshan Bay, Fujian

| PRJNA1439933 | ENA

Mapping and dynamics of regulatory DNA in A. thaliana accessions

Project description:We performed DNase-seq on 7-day-old seedlings from four A. thaliana accessions: Bur-0, Tsu-0, Bay-0, Est-1 using INTACT constructs (Deal and Henikoff, Developmental Cell, 2010) driven by the UBQ10 promoter. Chromatin accessibility profiling (Dnase I-seq) of 7-day-old seedlings of A. thaliana accessions: Bur-0, Tsu-0, Bay-0 & Est-1 grown in LD conditions (16hr light 22Â°C, 8hr dark 20Â°C).

2013-12-15 | E-GEOD-53323 | biostudies-arrayexpress

Dual antiviral and anti-inflammatory effects of BAY 11-7082 in SARS-CoV-2 infection via inhibition of the canonical NF-κB signaling pathway_[supplementary Fig.1]

Project description:The continued emergence of SARS-CoV-2 variants and persistent inflammatory complications of COVID-19 highlight the urgent need for therapeutics with both antiviral and anti-inflammatory properties. Despite intensive global efforts, no approved antiviral therapy with these dual functions has yet been developed, representing a significant gap in current COVID-19 treatment strategies. In this study, we identify BAY 11-7082 (BAY) as a dual–action compound that inhibits SARS-CoV-2 replication and the production of virus-induced proinflammatory cytokines and chemokines, including IL-6, IL-8, CXCL1, and CXCL2. BAY predominantly exerts its antiviral activity at the post-entry stage of the viral life cycle. Mechanistically, BAY potentially interacts with SARS-CoV-2 NSP14 and inhibits virus-induced phosphorylation and degradation of IκBα, suppressing NF-κB activation through the IKK-IκBα signaling axis. Furthermore, BAY exhibits potent antiviral activity against multiple SARS-CoV-2 variants of concern (VOCs). Collectively, these findings support the potential of BAY as a dual-action therapeutic candidate, combining antiviral and anti-inflammatory effects, against SARS-CoV-2 and its emerging variants.

2026-04-03 | GSE310278 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data